2014
DOI: 10.1186/1471-2458-14-877
|View full text |Cite
|
Sign up to set email alerts
|

An update on the prevalence of metabolic syndrome and its associated factors in rural northeast China

Abstract: BackgroundThe last study reported the prevalence of Metabolic Syndrome (MetS) in rural Northeast China was conducted approximately ten years ago. We aimed to update the data on the prevalence and epidemiological features of MetS in rural Northeast China.MethodsThis survey was conducted from July 2012 to August 2013. In this study, a total of 11,496 residents from the rural Northeast China were randomly selected and examined. MetS was defined according to the ATPIII-modified criteria. Data regarding the demogra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
98
5

Year Published

2015
2015
2019
2019

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 82 publications
(111 citation statements)
references
References 35 publications
8
98
5
Order By: Relevance
“…Other studies conducted in Iran and other parts of the world reported a higher prevalence for MS. The prevalence of this disorder among adults was 38.5% in the United States [9], 27.8% in Spain [32], 21.1% in France [10], 25.9% in Norway [33], 54.8% in Mexico [11], 35.73% in Morocco [2], 30% in Tanzania [34], 25% in Korea [35], 21.3 -39% in China [12,13], 40-50% in India [36], 21% in Saudi Arabia [14], 36.3% in Jordan [37], 33.5% in Turkey [15], and 21.9% -32% in different regions of Iran [16][17][18][19][20][21][22][23]. Possible reasons for this difference and lower prevalence of MS, are racial and regional differences, age differences between studies, and the use of different definitions for MS.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Other studies conducted in Iran and other parts of the world reported a higher prevalence for MS. The prevalence of this disorder among adults was 38.5% in the United States [9], 27.8% in Spain [32], 21.1% in France [10], 25.9% in Norway [33], 54.8% in Mexico [11], 35.73% in Morocco [2], 30% in Tanzania [34], 25% in Korea [35], 21.3 -39% in China [12,13], 40-50% in India [36], 21% in Saudi Arabia [14], 36.3% in Jordan [37], 33.5% in Turkey [15], and 21.9% -32% in different regions of Iran [16][17][18][19][20][21][22][23]. Possible reasons for this difference and lower prevalence of MS, are racial and regional differences, age differences between studies, and the use of different definitions for MS.…”
Section: Discussionmentioning
confidence: 99%
“…in Mexico [11], 35.73% in Morocco [2], 21.3% -39% in China [12,13], 21% in Saudi Arabia [14], 33.5% in Turkey [15], and 21.9% -32% in different regions of Iran [16][17][18][19][20][21][22][23].…”
Section: Introductionmentioning
confidence: 99%
“…A total of 18 studies (22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39) were selected for inclusion in this metaanalysis. Table E4 outlines the characteristics of study participants.…”
Section: Resultsmentioning
confidence: 99%
“…Studies done in Korea also showed an increased prevalence of MetS in men. However, studies from China indicate a higher prevalence of MetS in women, both rural and urban, than in men [23,24].…”
Section: Epidemiology Of Metabolic Syndrome -Sex Differencesmentioning
confidence: 97%